Stratasys announced on January 14, 2025, the commercial launch of its TrueDent-D™ resin in Europe, available as a CE Mark Class I medical device. This milestone enables the sale of its TrueDent™ monolithic multi-shade digital denture solution in European countries requiring CE marking.
Following its successful debut in the United States in 2023, TrueDent is poised to deliver a scalable, efficient, and high-quality solution for denture production across Europe. The European denture market is projected to grow from $2.19 billion in 2023 to $2.45 billion by 2028, presenting a significant opportunity.
The TrueDent solution allows dental labs to produce customized dentures efficiently, reducing the total cost by more than 50% compared to traditional methods. With over 30 customers already committed for Q1 2025, this expansion positions Stratasys to capture a growing share of the digital dentistry market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.